2-羟基-4-氨基-5-羟甲基嘧啶, 98%

5-(Hydroxymethyl)cytosine

N-(2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙基)-2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚啉-4-基)氧基)乙酰胺盐酸盐, 98%

N-(2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide hydrochloride

N-氨基甲酰基-2-氟-β-丙氨酸

3-(carbamoylamino)-2-fluoropropanoic acid

98%

异绒白乳菇醛

(1aS,3aS,6aS,6bR)-5,5,6b-trimethyl-3a,4,5,6,6a,6b-hexahydrocyclopropa[e]indene-1a,2(1H)-dicarbaldehyde

≥99.9%

舒巴坦钠, ≥98%

Sulbactam Sodium Salt

5-(2-hydroxyethoxy)-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one

Hidiosmin

Boc-S-3-硝基-2-吡啶亚磺酰基-D-半胱氨酸, 99%

Boc-D-Cys(NPys)-OH

3-甲氧基-2-呋喃醛, 98%

3-Methoxyfuran-2-carbaldehyde

6''-O-乙酰黄豆黄苷, ≥99%

6''-O-Acetylglycitin

N-乙酰基-S-（2-羟基-1-苯乙基）-L-半胱氨酸+ N-乙酰基-S-（2-羟基-2-苯乙基）-L-半胱氨酸（混合物）

N-Acetyl-S-(2-hydroxy-1-phenylethyl)-L-cysteine + N-Acetyl-S-(2-hydroxy-2-phenylethyl)-L-cysteine (Mixture)

4-(三氟甲基)-2-吡啶甲酸乙酯, ≥98%

Ethyl 4-(trifluoromethyl)picolinate

结核硬脂酸

10-methyloctadecanoic acid

In ethanol

ADX88178, >99%

ADX88178

Atrasentan, 99%

Atrasentan

Cathepsin Inhibitor 1, 99.9%

Cathepsin Inhibitor 1

CNX-1351 , ≥99.9%

CNX-1351 

1-氨基-3-(对甲苯基)苯并[4,5]咪唑并[1,2-a]吡啶-2,4-二甲腈, 99%

1-Amino-3-p-tolyl-benzo[4,5]imidazo[1,2-a]pyridine-2,4-dicarbonitrile

Erdafitinib (JNJ-42756493), 99.9%

Erdafitinib (JNJ-42756493)

2-thio-PAF, 99%, 5mg in 200μl Ethanol

2-thio-PAF

GDC-0834 , ≥99.9%

GDC-0834